Atlas Trials

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Clinical trial NCT04704661 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04704661
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal CarcinomaAdvanced Endometrial CarcinomaAdvanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Malignant Solid NeoplasmAdvanced Salivary Gland CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Start date
2021-08-09
Primary completion
2027-03-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.